Micronutrients, N-acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression

Nutrients

Volumn 2, Issue 6, 2010, Pages 626-651

  Hummelen, Ruben ^a,b   Hemsworth, Jaimie ^c   Reid, Gregor ^b,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c BRESCIA UNIVERSITY COLLEGE   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

AIDS; HIV; Micronutrients; N acetyl cysteine; Prebiotics; Probiotics; Selenium; Zinc

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; DAPSONE; DEFEROXAMINE; FOLIC ACID; GLUTATHIONE; IRON; MULTIVITAMIN; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RETINOL; SELENIUM; TRACE ELEMENT; VITAMIN B GROUP; VITAMIN D; ZINC;

ANEMIA; CD4 LYMPHOCYTE COUNT; CELL ACTIVITY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG MEGADOSE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; IRON DEFICIENCY; LOW BIRTH WEIGHT; LOW DRUG DOSE; MORTALITY; NATURAL KILLER CELL; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMOCYSTIS PNEUMONIA; PREGNANCY OUTCOME; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOL DEFICIENCY; REVIEW; RISK REDUCTION; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS INFECTIVITY; VIRUS LOAD; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 79951683460     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu2060626     Document Type: Review

References (106)

1. NAIDS. AIDS epidemic update, November 2009. Available online: www.data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf (accessed on 1 April 2010).
2. WHO. Towards Universal Access, Scaling up Priority HIV/AIDS Interventions in the Health Sector, Progress Report 2009. Available online: www.who.int/hiv/pub/2009progressreport/en/(accessed on 1 April 2010).
3. WHO. Technical Consultation on Nutrient Requirements for People Living with HIV/AIDS. Geneva, Switzerland, May 13-15 2003. Available online: www.who.int/nutrition/publications/Content_nutrient_requirements.pdf (accessed on 4 March 2010).
4. Batterham, M.J. Investigating Heterogeneity in Studies of Resting Energy Expenditure in Persons with HIV/AIDS, a Meta-analysis. Am. J. Clin. Nutr. 2005, 81, 702-713.
5. Macallan, D.C.; Noble, C.; Baldwin, C.; Jebb, S.A.; Prentice, A.M.; Coward, W.A.; Sawyer, M.B.; McManus, T.J.; Griffin, G.E., Energy Expenditure and Wasting in Human Immunodeficiency virus Infection. N. Eng. J. Med. 1995, 333, 83-88.
6. Allard, J.P.; Aghdassi, E.; Chau, J.; Salit, I.; Walmsley, S. Oxidative Stress and Plasma Antioxidant Micronutrients in Humans with HIV Infection. Am. J.Clin. Nutr. 1998, 67, 143-147.
7. Knox, T.A.; Spiegelman, D.; Skinner, S.C.; Gorbach, S. Diarrhea and Abnormalities of Gastrointestinal Function in a Cohort of Men and Women with HIV Infection. Am. J. Gastroenterol. 2000, 95, 3482-3489.
8. Marston, B.; De. Cock, K.M. Multivitamins, Nutrition, and Antiretroviral Therapy for HIV Disease in Africa. N. Eng. J. Med. 2004, 351, 78-80.
9. Irlam, J.H.; Visser, M.E.; Rollins, N. Siegfried N, Micronutrient Supplementation in Children and Adults with HIV Infection. Cochrane Database Syst. Rev. 2005, CD003650.
10. Beach, R.; Mantero-Atienza, E.; Shor-Posner, G. Specific Nutrient Abnormalities in Asymptomatic HIV-1 Infection. AIDS 1992, 6, 701-708.
11. Fawzi, W. Micronutrients and Human Immunodeficiency Virus Type 1 Disease Progression among Adults and Children. Clin. Infect. Dis. 2003, 37, S112-S116.
12. Dietary Reference Intakes, The Essential Guide to Nutrient Requirements. 2004 (Institute of Medicine website) Available online: www.iom.edu/en/Global/News%20Announcements/~/media/Files/Activity%20Files/Nutrition/DRIs/DRISummaryListing2.ashx (Accessed on 1 April 2010).
13. Semba, R.D. The Role of Vitamin A and Related Retinoids in Immune Function. Nutr. Rev. 1998, 56, S38-S48.
14. Fawzi, W.W.; Chalmers, T.C.; Herrera, M.G.; Mosteller, F. Vitamin A Supplementation and Child Mortality. A Meta-analysis. JAMA 1993, 269, 898-903.
15. Semba, R.D.; Miotti, P.G.; Chiphangwi, J.D.; Saah, A.J.; Canner, J.K.; Dallabetta, G.A.; Hoover, D.R. Maternal Vitamin A Deficiency and Mother-to-child Transmission of HIV-1. Lancet 1994, 343, 1593-1597.
16. Semba, R.D.; Graham, N.M.; Caiaffa, W.T.; Margolick, J.B.; Clement, L.; Vlahov, D. Increased Mortality Associated with Vitamin A Deficiency during Human Immunodeficiency virus Type 1 Infection. Arch Int. Med. 1993, 153, 2149-2154.
17. Tang, A.M.; Graham, N.M.; Semba, R.D.; Saah, A.J. Association Between Serum Vitamin A and E Levels and HIV-1 Disease Progression. AIDS 1997, 11, 613-620.
18. Fawzi, W.W.; Mbise, R.L.; Hertzmark, E.; Fataki, M.R.; Herrera, M.G.; Ndossi, G.; Spiegelman, D. A Randomized Trial of Vitamin A Supplements in Relation to Mortality among Human Immunodeficiency Virus-infected and Uninfected Children in Tanzania. Pediatr. Infect. Dis. J. 1999, 18, 127-133.
19. Semba, R.D.; Ndugwa, C.; Perry, R.T.; Clark, T.D.; Jackson, J.B.; Melikian, G.; Tielsch, J.; Mmiro, F. Effect of Periodic Vitamin A Supplementation on Mortality and Morbidity of Human Immunodeficiency Virus-infected Children in Uganda, A Controlled Clinical Trial. Nutrition 2005, 21, 25-31.
20. Coutsoudis, A.; Pillay, K.; Spooner, E.; Kuhn, L.; Coovadia, H.M. Randomized Trial Testing the Effect of Vitamin A Supplementation on Pregnancy Outcomes and Early Mother-to-child HIV-1 Transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999, 13, 1517-1524.
21. Kumwenda, N.; Miotti, P.G.; Taha, T.E.; Broadhead, R.; Biggar, R.J.; Jackson, J.B.; Melikian, G.; Semba, R.D. Antenatal Vitamin A Supplementation Increases Birth Weight and Decreases Anemia among Infants Born to Human Immunodeficiency Virus-infected Women in Malawi. Clin. Infect. Dis. 2002, 35, 618-624.
22. Fawzi, W.W.; Msamanga, G.I.; Hunter, D.; Renjifo, B.; Antelman, G.; Bang, H.; Manji, K.; Kapiga, S.; Mwakagile, D.; Essex, M.; Spiegelman, D.; Randomized Trial of Vitamin Supplements in Relation to Transmission of HIV-1 through Breastfeeding and Early Child Mortality. AIDS 2002, 16, 1935-1944.
23. Fawzi, W.; Msamanga, G.; Spiegelman, D. Randomized Trial of Effects of Vitamin Supplements on Pregnancy Outcomes and T Cell Counts in HIV-1-infected Women in Tanzania. Lancet 1998, 351, 1477-1482.
24. Fawzi, W.W.; Msamanga, G.I.; Spiegelman, D.; Wei, R.; Kapiga, S.; Villamor, E.; Mwakagile, D.; Mugusi, F.; Hertzmark, E.; Essex, M.; Hunter, D.J. A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality. N. Eng. J. Med.2004, 351, 23-32.
25. Fawzi, W.W.; Msamanga, G.I.; Spiegelman, D.; Urassa, E.J.; McGrath, N.; Mwakagile, D.; Antelman, G.; Mbise, R.; Herrera, G.; Kapiga, S.; Willett, W.; Hunter, D.J. Randomized Trial of Effects of Vitamin Supplements on Pregnancy Outcomes and T Cell Counts in HIV-1-infected Women in Tanzania. Lancet 1998, 351, 1477-1482.
26. Villamor, E.; Saathoff, E.; Manji, K.; Msamanga, G.; Hunter, D.J.; Fawzi, W.W. Vitamin Supplements, Socioeconomic Status, and Morbidity Events as Predictors of Wasting in HIV Infected Women from Tanzania. Am. J. Clin. Nutr. 2005, 82, 857-865.
27. Drain, P.K.; Kupka, R.; Mugusi, F.; Fawzi, W.W. Micronutrients in HIV-positive Persons Receiving Highly Active Antiretroviral Therapy. Am. J. Clin. Nutr. 2007, 85, 333-345.
28. Tang, A.; Graham, N.; Saah, A. Effects of Micronutrient Intake on Survival in Human Immunodeficiency virus Type 1 Infection. Am. J. Epi. 1996, 143, 1244-1256.
29. Tang, A.M.; Graham, N.M.; Chandra, R.K.; Saah, A.J. Low Serum Vitamin B-12 Concentrations are Associated with Faster Human Immunodeficiency virus type 1 (HIV-1) Disease Progression. J. Nutr. 1997, 127, 345-351.
30. Kanter, A.S.; Spencer, D.C.; Steinberg, M.H.; Soltysik, R.; Yarnold, P.R.; Graham, N.M. Supplemental Vitamin B and Progression to AIDS and Death in Black South African Patients Infected with HIV. J. Acquir. Immune Defic. Syndr. 1999, 21, 252-253.
31. Baum, M.; Cassetti, L.; Bonvehi, P. Inadequate Dietary Intake and Altered Nutrition Status in Early HIV-1 Infection. Nutrition 1994, 10, 16-20.
32. Schreck, R.; Rieber, P.; Baeuerle, P.A. Reactive Oxygen Intermediates as Apparently Widely Used Messengers in the Activation of the NF-kappa B Transcription Factor and HIV-1. EMBO J. 1991, 10, 2247-2258.
33. Abrams, B.; Duncan, D.; Hertz-Picciotto, I. A Prospective Study of Dietary Intake and Acquired Immune Deficiency Syndrome in HIV-seropositive Homosexual Men. J. Acquir. Immune Defic. Syndr. 1993, 6, 949-958.
34. Kelly, P.; Musonda, R.; Kafwembe, E.; Kaetano, L.; Keane, E.; Farthing, M. Micronutrient Supplementation in the AIDS Diarrhoea-wasting Syndrome in Zambia, a Randomized Controlled Trial. AIDS 1999, 13, 495-500.
35. Allard, J.P.; Aghdassi, E.; Chau, J.; Tam, C.; Kovacs, C.M.; Salit, I.E.; Walmsley, S.L. Effects of Vitamin E and C Supplementation on Oxidative Stress and Viral Load in HIV-infected Subjects. AIDS 1998, 12, 1653-1659.
36. McClelland, R.S.; Baeten, J.M.; Overbaugh, J.; Richardson, B.A.; Mandaliya, K.; Emery, S.; Lavreys, L.; Ndinya-Achola, J.O.; Bankson, D.D.; Bwayo, J.J.; Kreiss, J.K. Micronutrient Supplementation Increases Genital tract Shedding of HIV-1 in Women, Results of a Randomized Trial. J. Acquir. Immune Defic. Syndr. 2004, 37, 1657-1663.
37. Jiamton, S.; Pepin, J.; Suttent, R. A Randomized Trial of the Impact of Multiple Micronutrient Supplementation on Mortality among HIV-infected individuals Living in Bangkok. AIDS 2003, 17, 2461-2469.
38. Kaiser, J.D.; Adriana, M.C.; Ondercin, J.P.; Gifford, S.L.; Pless, R.F.; Baum, M.K. Micronutrient Supplementation Increases CD4 Count in HIV-infected Individuals on Highly Active Antiretroviral Therapy, a Prospective, Double-blinded, Placebo-controlled Trial. J. Acquir. Immune Defic. Syndr. 2006, 42, 523-528.
39. Bhalla, A.K.; Amento, E.P.; Clemens, T.L.; Holick, M.F.; Krane, S.M. Specific High-affinity Receptors for 1,25-dihydroxyvitamin D3 in Human Peripheral Blood Mononuclear cells, Presence in Monocytes and Induction in T Lymphocytes Following Activation. J. Clin. Endocrinol. Metab. 1983, 57, 1308-1310.
40. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C.; Kamen, D.L.; Wagner, M.; Bals, R.; Steinmeyer, A.; Zugel, U.; Gallo, R.L.; Eisenberg, D.; Hewison, M.; Hollis, B.W.; Adams, J.S.; Bloom, B.R.; Modlin, R.L. Toll-like Receptor Triggering of a Vitamin D-mediated Human Antimicrobial Response. Science 2006, 311, 1770-1773.
41. Mehta, S.; Hunter, D.J.; Mugusi, F.M.; Spiegelman, D.; Manji, K.P.; Giovannucci, E.L.; Hertzmark, E.; Msamanga, G.I.; Fawzi, W.W. Perinatal Outcomes, Including Mother-to-Child Transmission of HIV, and Child Mortality and their Association with Maternal Vitamin D Status in Tanzania. J. Infect. Dis. 2009, 200, 1022-1030.
42. Wejse, C.; Gomes, V.F.; Rabna, P.; Gustafson, P.; Aaby, P.; Lisse, I.M.; Andersen, P.L.; Glerup, H.; Sodemann, M. Vitamin D as Supplementary Treatment for Tuberculosis, a Double-blind, Randomized, Placebo-controlled Trial. Am. J. Respir. Crit. Care Med. 2009, 179, 843-850.
43. Fawzi, W.W.; Msamanga, G.I.; Wei, R.; Spiegelman, D.; Antelman, G.; Villamor, E.; Manji, K.; Hunter, D. Effect of Providing Vitamin Supplements to Human Immunodeficiency Virus-infected, Lactating Mothers on the Child's Morbidity and CD4 cell Counts. Clin. Infect. Dis. 2003, 36, 1053-1062.
44. Jiamton, S.; Pepin, J.; Suttent, R.; Filteau, S.; Mahakkanukrauh, B.; Hanshaoworakul, W.; Chaisilwattanag, P.; Suthipinittharmb, P.; Shettyh, P.; Jaffara, S. A Randomized Trial of the Impact of Multiple Micronutrient Supplementation on Mortality among HIV-infected Individuals Living in Bangkok. AIDS 2003, 17, 2461-2469.
45. Kelly, P.; Katubulushi, M.; Todd, J.; Banda, R.; Yambayamba, V.; Fwoloshi, M.; Zulu, I.; Kafwembe, E.; Yavwa, F.; Sanderson, I.R.; Tomkins, A. Micronutrient Supplementation has Limited Effects on Intestinal Infectious Disease and Mortality in a Zambian Population of Mixed HIV Status, a Cluster Randomized Trial. Am. J. Clin. Nutr. 2008, 88, 1010-1017.
46. Sullivan, P.S.; Hanson, D.L.; Chu, S.Y.; Jones, J.L.; Ward, J.W. Epidemiology of Anemia in Human Immunodeficiency virus (HIV)-infected Persons, Results from the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project. Blood 1998, 91, 301-308.
47. O'Brien, M.E.; Kupka, R.; Msamanga, G.I.; Saathoff, E.; Hunter, D.J.; Fawzi, W.W. Anemia is an Independent Predictor of Mortality and Immunologic Progression of Disease among Women with HIV in Tanzania. J. Acquir. Immune Defic. Syndr. 2005, 40, 219-225.
48. Gordeuk, V.R.; Delanghe, J.R.; Langlois, M.R.; Boelaert, J.R. Iron Status and the Outcome of HIV Infection, an Overview. J. Clin. Virol. 2001, 20, 111-115.
49. Costagliola, D.G.; De Montalembert, M.; Lefrere, J.J.; Briand, C.; Rebulla, P.; Baruchel, S.; Dessi, C.; Fondu, P.; Karagiorga, M.; Perrimond, H. Dose of Desferrioxamine and Evolution of HIV-1 Infection in Thalassaemic Patients. Br. J. Haematol. 1994, 87, 849-852.
50. Salhi, Y.; Costagliola, D.; Rebulla, P.; Dessi, C.; Karagiorga, M.; Lena-Russo, D.; de Montalembert, M.; Girot, R.; Serum Ferritin, Desferrioxamine, and Evolution of HIV-1 Infection in Thalassemic Patients. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1998, 18, 473-478.
51. Salmon-Ceron, D.; Fontbonne, A.; Saba, J.; May, T.; Raffi, F.; Chidiac, C.; Patey, O.; Aboulker, J.P.; Schwartz, D.; Vilde, J.L. Lower Survival in AIDS Patients Receiving Dapsone Compared with Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia. Study Group. J. Infect. Dis. 1995, 172, 656-664.
52. Bozzette, SA.; Finkelstein, DM.; Spector, SA.; Frame, P.; Powderly, WG.; He, W.; Phillips, L.; Craven, D.; van der Horst, C.; Feinberg, J. A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection. NIAID AIDS Clinical Trials Group. N. Eng. J. Med. 1995, 332, 693-699.
53. Delanghe, JR.; Langlois, MR.; Boelaert, JR.; Van, Acker J.; Van, Wanzeele F.; Van, Der Groen G.; Hemmer, R.; Verhofstede, C.; De Buyzere, M.; De Bacquer, D.; Arendt, V.; Plum, J. Haptoglobin Polymorphism, Iron Metabolism and Mortality in HIV Infection. AIDS 1998, 12, 1027-1032.
54. Monye, C.; Karcher, D.S.; Boelaert, J.R.; Gordeuk, V.R. Bone Marrow Macrophage Iron Grade and Survival of HIV-seropositive Patients. AIDS 1999, 13, 375-380.
55. Olsen, A.; Mwaniki, D.; Krarup, H.; Friis, H. Low-dose Iron Supplementation does not Increase HIV-1 load. J. Acquir. Immune Defic. Syndr. 2004, 36, 637-638.
56. Semba, R.D.; Kumwenda, J.; Zijlstra, E.; Ricks, M.O.; Lettow, M.; Whalen, C.; Clark, T.D.; Jorgensen, L.; Kohler, J.; Kumwenda, N.; Taha, T.E.; Harries, A.D. Micronutrient Supplements and Mortality of HIV-infected Adults with Pulmonary TB, A Controlled Clinical Trial. Int. J. Tuberc. Lung Dis. 2007, 11, 854-859.
57. Kupka, R.; Fawzi, W. Zinc nutrition and HIV infection. Nutr. Rev. 2002, 60, 69-79.
58. Black, R.E. Therapeutic and Preventive Effects of Zinc on Serious Childhood Infectious Diseases in Developing Countries. Am. J. Clin. Nutr. 1998, 68, 476S-479S.
59. Mocchegiani, E.; Veccia, S.; Ancarani, F.; Scalise, G.; Fabris, N. Benefit of Oral Zinc Supplementation as an Adjunct to Zidovudine (AZT) Therapy against Opportunistic Infections in AIDS. Int. J. Immunopharm.1995, 17, 719-727.
60. Tang, A.M.; Graham, N.M.; Saah, A.J. Effects of Micronutrient Intake on Survival in Human Immunodeficiency virus Type 1 Infection. Am. J. Epi. 1996, 143, 1244-1256.
61. Lai, H.; Lai, S.; Shor-Posner, G.; Ma, F.; Trapido, E.; Baum, M.K. Plasma Zinc, Copper, Copper,zinc Ratio, and Survival in a Cohort of HIV-1-infected Homosexual Men. J. Acquir. Immune Defic. Syndr. 2001, 27, 56-62.
62. Bobat, R.; Coovadia, H.; Stephen, C.; Naidoo, K.L.; McKerrow, N.; Black, R.E.; Moss, W.J. Safety and Efficacy of Zinc Supplementation for Children with HIV-1 Infection in South Africa, a Randomized Double-blind Placebo-controlled Trial. Lancet 2005, 366, 1862-1867.
63. Fawzi, W.W.; Villamor, E.; Msamanga, G.I.; Antelman, G.; Aboud, S.; Urassa, W.; Hunter, D. Trial of Zinc Supplements in Relation to Pregnancy Outcomes, Hematologic Indicators, and T Cell Counts among HIV-1-infected Women in Tanzania. Am. J. Clin. Nutr. 2005, 81, 161-167.
64. Villamor, E.; Aboud, S.; Koulinska, IN.; Kupka, R.; Urassa, W.; Chaplin, B.; Msamanga, G.; Fawzi, W.W. Zinc Supplementation to HIV-1-infected Pregnant Women, Effects on Maternal Anthropometry, Viral Load, and Early Mother-to-child Transmission. Eur. J. Clin. Nutr. 2006, 60, 862-869.
65. Campa, A.; Shor-Posner, G.; Indacochea, F.; Zhang, G.; Lai, H.; Asthana, D.; Scott, G.B.; Baum, M.K. Mortality Risk in Selenium-deficient HIV-positive Children. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1999, 20, 508-513.
66. Kupka, R.; Msamanga, GI.; Spiegelman, D.; Morris, S.; Mugusi, F.; Hunter, D.J.; Fawzi, W.W. Selenium Status is Associated with Accelerated HIV Disease Progression among HIV-1-infected Pregnant Women in Tanzania. J. Nutr. 2004, 134, 2556-2560.
67. Constans, J.; Pellegrin, J.L.; Sergeant, C.; Simonoff, M.; Pellegrin, I.; Fleury, H.; Leng, B.; Conri, C. Serum Selenium Predicts Outcome in HIV Infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10, 392.
68. Cirelli, A.; Ciardi, M.; Simone, C.; Sorice, F.; Giordano, R.; Ciaralli, L.; Costantini, S. Serum Selenium Concentration and Disease Progress in Patients with HIV Infection. Clin. Biochem. 1991, 24, 211-214.
69. Spallholz, J.E.; Boylan, L.M.; Larsen, H.S. Advances in Understanding Selenium's Role in the Immune System. Ann. N. Y. Acad. Sci. 1990, 587, 123-139.
70. Constans, J.; Delmas-Beauvieux, M.C.; Sergeant, C.; Peuchant, E.; Pellegrin, J.L.; Pellegrin, I.; Pellegrin, I.; Clerc, M.; Fleury, H.; Simonoff, M.; Leng, B.; Conri, C. One-year antioxidant Supplementation with Beta-Carotene or Selenium for Patients Infected with Human Immunodeficiency Virus, a Pilot Study. Clin. Infect. Dis. 1996, 23, 654-656.
71. Burbano, X.; Miguez-Burbano, M.J.; McCollister, K.; Zhang, G.; Rodriguez, A.; Ruiz, P.; Lecusay, R.; Shor-Posner, G. Impact of a Selenium Chemoprevention Clinical Trial on Hospital Admissions of HIV-infected Participants. HIV Clin. Trials 2002, 3, 483-491.
72. Hurwitz, B.E.; Klaus, J.R.; Llabre, M.M.; Gonzalez, A.; Lawrence, P.J.; Maher, K.J.; Greeson, J.M.; Baum, M.K.; Shor-Posner, G., Skyler, J.S.; Schneiderman, N. Suppression of Human Immunodeficiency Virus Type 1 Viral Load with Selenium Supplementation, a Randomized Controlled Trial. Arch. Int. Med. 2007, 167, 148-154.
73. Kupka, R.; Mugusi, F.; Aboud, S.; Msamanga, G.I.; Finkelstein, J.L.; Spiegelman, D.; Fawzi, W.W. Randomized, Double-Blind, Placebo-Controlled Trial of Selenium Supplements among HIV-Infected Pregnant Women in Tanzania, Effects on Maternal and Child Outcomes. Am. J. Clin. Nutr. 2008, 87, 1802-1808.
74. Herzenberg, L.A.; Rosa, S.C.; Dubs, J.G.; Roederer, M.; Anderson, M.T.; Ela, S.W.; Deresinski, S.C.; Herzenberg, L.A. Glutathione Deficiency is Associated with Impaired Survival in HIV Disease. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 1967-1972.
75. Akerlund, B.; Jarstrand, C.; Lindeke, B.; Sonnerborg, A.; Akerblad, A.C.; Rasool, O. Effect of Nacetylcysteine(NAC) Treatment on HIV-1 Infection, a Double-Blind Placebo-Controlled Trial. Eur. J. Clin. Pharmaco. 1996, 50, 457-461.
76. Breitkreutz, R.; Pittack, N.; Nebe, C.T.; Schuster, D.; Brust, J.; Beichert, M.; Hack, V.; Daniel, V.; Edler, L.; Droge, W. Improvement of Immune Functions in HIV Infection by Sulfur Supplementation, two Randomized Trials. J. Mol. Med. 2000, 78, 55-62.
77. Look, M.P.; Rockstroh, J.K.; Rao, G.S.; Barton, S.; Lemoch, H.; Kaiser, R.; Kupfer, B.; Sudhop, T.; Spengler, U.; Sauerbruch, T.; Sodium Selenite and N-acetylcysteine in Antiretroviral-Naïve HIV-1-Infected Patients, a Randomized, Controlled Pilot Study. Eur. J. Clin. Invest. 1998, 28, 389-397.
78. Micke, P.; Beeh, K.M.; Buhl, R. Effects of Long-Term Supplementation with Whey Proteins on Plasma Glutathione Levels of HIV-Infected Patients. Eur. J. Nutr. 2002, 41, 12-18.
79. Sattler, F.R.; Rajicic, N.; Mulligan, K.; Yarasheski, K.E.; Koletar, S.L.; Zolopa, A.; Alston Smith, B.; Zackin, R.; Bistrian, B. Evaluation of High-Protein Supplementation in Weight-Stable HIVPositive Subjects with a History of Weight Loss, a Randomized, Double-Blind, Multicenter Trial. Am. J. Clin. Nutr. 2008, 88, 1313-1321.
80. Mehandru, S.; Poles, M.A.; Tenner-Racz, K.; Horowitz, A.; Hurley, A.; Hogan, C.; Boden, D.; Racz, P.; Markowitz, M. Primary HIV-1 Infection is Associated with Preferential Depletion of CD4 T Lymphocytes from Effector Sites in the Gastrointestinal Tract. J. Exp. Med. 2004, 200, 761-770.
81. Noyer, C.M.; Simon, D.; Borczuk, A.; Brandt, L.J.; Lee, M.J.; Nehra, V. A Double-Blind Placebo-Controlled Pilot study of Glutamine Therapy for Abnormal Intestinal Permeability in Patients with AIDS. Am. J. Gastroent. 1998, 93, 972-975.
82. Brenchley, J.M.; Price, D.A.; Schacker, T.W.; Asher, T.E.; Silvestri, G.; Rao, S.; Kazzaz, Z.; Bornstein, E.; Lambotte, O.; Altmann, D.; Blazar, B.R.; Rodriguez, B.; Teixeira-Johnson, L.; Landay, A.; Martin, J.N.; Hecht, F.M.; Picker, L.J.; Lederman, M.M.; Deeks, S.G.; Douek, D.C. Microbial Translocation is a Cause of Systemic Immune Activation in Chronic HIV Infection. Nat. Med. 2006, 12, 1365-1371.
83. Gori, A.; Tincati, C.; Rizzardini, G.; Torti, C.; Quirino, T.; Haarman, M.; Ben Amor, K.; van Schaik, J.; Vriesema, A.; Knol, J.; Marchetti, G.; Welling, G.; Clerici, M. Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis. J. Clin. Micro. 2008, 46, 757-758.
84. Sindhu, S.; Toma, E.; Cordeiro, P.; Ahmad, R.; Morisset, R.; Menezes, J. Relationship of in vivo and ex vivo Levels of TH1 and TH2 Cytokines with Viremia in HAART Patients with and without Opportunistic Infections. J. Med. Vir. 2006, 78, 431-439.
85. Buonaguro, L.; Tornesello, M.L.; Gallo, R.C.; Marincola, F.M; Lewis, G.K.; Buonaguro, F.M. Th2 Polarization in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus (HIV)-infected Subjects, as Activated by HIV Virus-like Particles. J. Vir. 2009, 83, 304-313.
86. Wolf, B.W.; Wheeler, K.B.; Ataya, D.G.; Garleb, K.A. Safety and Tolerance of Lactobacillus Reuteri Supplementation to a Population Infected with the Human Immunodeficiency Virus. Food. Chem. Toxicol. 1998, 36, 1085-1094.
87. WHO/FAO. Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, a joint FAO/WHO expert consultation. October 1-4, 2001 (WHO website) Available online: www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf (Accessed on 4 March 2010).
88. Ukena, S.N.; Singh, A.; Dringenberg, U.; Engelhardt, R.; Seidler, U.; Hansen, W.; Bleich, A.; Bruder, D.; Franzke, A.; Rogler, G.; Suerbaum, S.; Buer, J.; Gunzer, F.; Westendorf, A.M. Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity. PloS One 2007, 2, 1308.
89. Rayes, N.; Seehofer, D.; Theruvath, T.; Schiller, R.A.; Langrehr, J.M.; Jonas, S.; Bengmark, S.; Neuhaus, P. Supply of Pre- and Probiotics Reduces Bacterial Infection Rates after Liver Transplantation--a Randomized, Double-blind Trial. Am. J. Transplant. 2005, 5, 125-130.
90. Isolauri, E.; Majamaa, H.; Arvola, T.; Rantala, I.; Virtanen, E.; Arvilommi, H. Lactobacillus Casei Strain GG Reverses Increased Intestinal Permeability Induced by Cow Milk in Suckling Rats. Gastroenterology 1993, 105, 1643-1650.
91. Madsen, K.; Cornish, A.; Soper, P.; McKaigney, C.; Jijon, H.; Yachimec, C.; Doyle, J.; Jewell, L.; De Simone, C. Probiotic Bacteria Enhance Murine and Human Intestinal Epithelial Barrier Function. Gastroenterology 2001, 121, 580-591.
92. O'Mahony, L.; McCarthy, J.; Kelly, P.; Hurley, G.; Luo, F.; Chen, K.; O'Sullivan, G.C.; Kiely, B.; Collins, J.K.; Shanahan, F.; Quigley, E.M. Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome, Symptom Responses and Relationship to Cytokine Profiles. Gastroenterology 2005, 128, 541-551.
93. Braat, H.; Brande, J.; Tol, E.; Hommes, D.; Peppelenbosch, M.; Deventer, S. Lactobacillus Rhamnosus Induces Peripheral Hyporesponsiveness in Stimulated CD4 T Cells via Modulation of Dendritic Cell Function. Am. J. Clin. Nutr. 2004, 80, 1618-1625.
94. Furrie, E.; Macfarlane, S.; Kennedy, A.; Cummings, J.H.; Walsh, S.V.; O'Neil, D.A.; Macfarlane, G.T. Synbiotic Therapy (Bifidobacterium longum/Synergy 1) Initiates Resolution of Inflammation in Patients with Active Ulcerative Colitis, a Randomized Controlled Pilot Trial. Gut 2005, 54, 242-249.
95. Rosenfeldt, V.; Benfeldt, E.; Nielsen, S.D.; Michaelsen, K.F.; Jeppesen, D.L.; Valerius, N.H.; Paerregaard, A. Effect of Probiotic Lactobacillus Strains in Children with Atopic Dermatitis. J. Allergy Clin. Immunol. 2003, 111, 389-395.
96. Trois, L.; Cardoso, E.M.; Miura, E. Use of Probiotics in HIV-infected Children, a Randomized Double-blind Controlled Study. J. Trop. Pediatr. 2008, 54, 19-24.
97. Anukam, K.C.; Osazuwa, E.O.; Osadolor, H.B.; Bruce, A.W.; Reid, G. Yogurt Containing Probiotic Lactobacillus Rhamnosus GR-1 and L. Reuteri RC-14 Helps Resolve Moderate Diarrhea and Increases CD4 Count in HIV/AIDS Patients. J. Clin. Gastroent. 2008, 42, 239-243.
98. Roberfroid, M. Prebiotics, the Concept Revisited. J. Nutr. 2007, 137, 8308-8378.
99. Cani, P.D.; Possemiers, S.; Vande Wiele T.; Guiot, Y.; Everard, A.; Rottier, O.; Geurts, L.; Naslain, D.; Neyrinck, A.; Lambert, D.M.; Muccioli, G.G.; Delzenne, N.M. Changes in Gut Microbiota Control Inflammation in Obese Mice through a Mechanism Involving GLP-2-Driven Improvement of Gut Permeability. Gut 2009, 58, 1091-1103.
100. Welters, C.F.; Heineman, E.; Thunnissen, F.B.; Bogaard, A.E.; Soeters, P.B.; Baeten, C.G. Effect of Dietary Inulin Supplementation on Inflammation of Pouch Mucosa in Patients with an Ileal Pouch-anal Anastomosis. Dis. Col. Rect. 2002, 45, 621-627.
101. Arslanoglu, S.; Moro, G.E.; Schmitt, J.; Tandoi, L.; Rizzardi, S.; Boehm, G. Early Dietary Intervention with a Mixture of Prebiotic Oligosaccharides Reduces the Incidence of Allergic Manifestations and Infections during the first two Years of Life. J. Nutr. 2008, 138, 1091-1095.
102. Hoffen, E.; Ruiter, B.; Faber, J.; M'Rabet, L.; Knol, EF.; Stahl, B.; Arslanoglu, S.; Moro, G.; Boehm, G.; Garssen, J. A Specific Mixture of Short-chain Galacto-oligosaccharides and Longchain Fructo-oligosaccharides Induces a Beneficial Immunoglobulin Profile in Infants at High Risk for Allergy. Allergy 2009, 64, 484-487.
103. Ben, Amor K.; Rizzardini, G.; Torti, C.; Quirino, T.; Moroni, M.; Knol, M.; Bray, D.; Vriesema, A.; Clerici, M.; Gori, A. Disturbed Gut Microbiota in HAART-naive HIV-1 Positive Adults: Effect of Intervention with a Specific Prebiotic. Proceedings of Oligosaccharide Mixture. Proceedings of 16th Conference on Retrovirus and Opportunistic Infections (CROI 2008), Boston, MA, USA, 2008.
104. Land, B.; Benlhassan-Chahour, K.; Rizzardini, G.; Vriesema, A.; Garssen, J.; Trabattoni, D.; Bray, D.; Gori, A.; Clerici, M. A Specific Mixture of Prebiotic Oligosaccharides Reduces Hyper-Immune Activation and Improves NK Cell Cytolytic Activity in HAART-naive HIV Positive Adults. Proceedings of 16th Conference on Retroviruses and Opportunistic Infections (CROI 2008), Boston, MA, USA. 2008.
105. Kerac, M.; Bunn, J.; Seal, A.; Thindwa, M.; Tomkins, A.; Sadler, K.; Bahwere, P.; Collins, S. Probiotics and Prebiotics for Severe Acute Malnutrition (PRONUT study), a Double-blind Efficacy Randomized Controlled Trial in Malawi. Lancet 2009, 374, 136-144.
106. Lange, J. Nutritional Formula Reduces CD4 Cell Decline in HIV Positive People Not Yet Taking Antiretroviral Therapy. Proceedings of 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2009), San Francisco, CA, USA, September 2009.